Primenenie v tkanevoy inzhenerii krupnykh sosudov transplantatov na osnove autogennykh mononuklearnykh kletok kostnogo mozga


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

В настоящее время эффективность операций по замене пораженных атеросклерозом и стенозированных крупных сосудов аутотрансплантатами, а также операций по ангиопластике, направленных на коррекцию врожденных дефектов сердечнососудистой системы, весьма невелика, и зачастую пациентам требуются повторные операции. В связи с этим необходима разработка искусственных тканеинженерных конструкций, обладающих достаточной прочностью и способных со временем замещаться тканями реципиента, обеспечивая формирование функционального сосуда. Обзор посвящен наиболее успешным доклиническим и клиническим исследованиям по данному направлению.

About the authors

A S Grigoryan

P V Kruglyakov

References

  1. Every N., Maynard С, Cochran R. et al. Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Circulation 1ЭЭБ; 94 (suppl. II): II-81-II-6.
  2. Kirklin J., Barratt-Boyes B. Ventricular septal defect and pulmonary stenosis or atresia. New York: Churchill Livingstone, 1993.
  3. Langer R., Vacanti J.P. Tissue Engineering. Science 1993; 2B0: 92D-6.
  4. L'Heureux N., Paquet S., Labbe R. et al. A completely biological tissue-engineered human blood vessel. FASEB J. 1998; 12: 47-5Б.
  5. Hoerstrup S.P., Zund G., Sodian R. et al. Tissue engineering of small caliber vascular grafts. Eur. J. Cardiothorac. Surg. 20D1; 2D: 164-9.
  6. Б. Sumpio B.E. Hemodynamic forces and vascular cell biology. Austin, TX: RG Landes Publishers; 1993; p.1-134.
  7. Kanda K., Matsuda Т., Oka T. In vitro reconstruction of hybrid vascular tissue. Hierarchic and oriented cell layers. ASAIO J. 1993; 39: M561-5.
  8. Kakisis J.D., Liapis CD., Breuer C. et al. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J. Vase. Surg. 2005; 41: 349-54.
  9. Homann M. Haehnel J.C., Mendler N. et al. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur. J. Cardiothorac. Surg. 2000; 17: 624-30.
  10. Bermudez C.A., Dearani J.A., Puga F.J. et al. Late results of the peel operation for replacement of failing extracardiac conduits. Ann. Thorac. Surg. 2004; 77: 881-8.
  11. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400.
  12. Shin'oka Т., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 2001; 344: 532-3.
  13. L'Heureux N., Germain L., Labbe R., Auger F.A. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J. Vase. Surg. 1993; 17: 499-509.
  14. Hirai J., Kanda K., Oka Т., Matsuda T. Highly oriented, tubular hybrid vascular tissue for a low pressure circulatory system. ASAIO J. 1994; 40: M383-8..
  15. Hirai J., Matsuda T. Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen: tissue regeneration process. Cell Transplant. 1996; 5: 93-105.
  16. ShinokaT., Shum-Tim D., Ma P.X. et al. Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 1998; 115: 532-46
  17. Shum-Tim D., Stock U., Hrkach J. et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac. Surg. 1999; 68: 2298-305.
  18. Niklason L.E., Gao J., Abbott W.M. et al. Functional arteries grown in vitro. Science 1999; 284: 489-93.
  19. Watanabe M., Shin'oka Т., Tohyama S. et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001;7:429-39.
  20. Hoerstrup S.P., Kadner A., Breymann С et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann. Thorac. Surg. 2002; 74: 46-52.
  21. Matsumura G., Miyagawa-Tomita S., Shin'oka T. et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circul. 2003; 108: 1729-34.
  22. Matsumura G., Ishihara Y., Miyagawa-Tomita S. et al. Evaluation of tissue-engineered vascular autografts. Tissue Eng. 2006; 12: 3075-83.
  23. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109.
  24. Ziche M., Morbidelli L., Masini E. et al. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem. Biophys. Res. Commun. 1993; 192: 1198.
  25. Babaei S., Teichert-Kuliszewska K., Zhang Q. et al. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am. J. Pathol. 2003; 162: 1927.
  26. Matsumura G., Hibino N., Ikada Y. et al. Successful application of tissue engineered vascular autografts: clinical experience. Biomat. 2003; 24: 2303-8.
  27. Shinoka Т., Breuer C.K., Tanel R.E. et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 1995; 60 [6 SupplJ: S513-6.
  28. Shinoka Т., Ma P.X., Shum-Tim D. et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circul. 1996; 94 [9 SupplJ: 11164-8.
  29. Shinoka Т., Shum-Tim D., Ma P.X. et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome? Circul. 1997; 96[9 SupplJ: 11102-7.
  30. Довгань A.M., Зиньковский М.Ф., Лазоришинец В.В. и др. Результаты операции Фонтена при аномалиях сердца с функционально единственным желудочком. Укранський Медичний Часопис 2000; 16: 76-80.
  31. Shinoka Т., Breuer С. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J. Biol. Med. 2008; 81: 161-6.
  32. McKay R. Stem cells-hype and hope. Nature 2000; 406: 361-4.
  33. Takahashi Т., Kalka C, Masuda H. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999; 5: 434-8.
  34. Shintani S., Murohara Т., Ikeda H. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circul. 2001; 103: 2776-9.
  35. Asahara Т., Masuda H., Takahashi T. et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999; 85: 221-8.

Copyright (c) 2009 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 85657 от 21.07.2023 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies